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Background: Salmonella enterica serotype Typhimurium produces surface-associated fimbriae that facilitate
adherence of the bacteria to a variety of cells and tissues. Type 1 fimbriae with binding specificity to mannose
residues are the most commonly found fimbrial type. In vitro, static-broth culture favors the growth of S.
Typhimurium with type 1 fimbriae, whereas non-type 1 fimbriate bacteria are obtained by culture on solid-agar
media. Previous studies demonstrated that the phenotypic expression of type 1 fimbriae is the result of the
interaction and cooperation of the regulatory genes fimZ, fimY, fimW, and fimU within the fim gene cluster.
Genome sequencing revealed a novel gene, stm0551, located between fimY and fimW that encodes an 11.4-kDa
putative phosphodiesterase specific for the bacterial second messenger cyclic-diguanylate monophosphate (c-di-
GMP). The role of stm0551 in the regulation of type 1 fimbriae in S. Typhimurium remains unclear.
Results: A stm0551-deleted stain constructed by allelic exchange constitutively produced type 1 fimbriae in both
static-broth and solid-agar medium conditions. Quantative RT-PCR revealed that expression of the fimbrial major
subunit gene, fimA, and one of the regulatory genes, fimZ, were comparably increased in the stm0551-deleted
strain compared with those of the parental strain when grown on the solid-agar medium, a condition that normally
inhibits expression of type 1 fimbriae. Following transformation with a plasmid possessing the coding sequence of
stm0551, expression of fimA and fimZ decreased in the stm0551 mutant strain in both culture conditions, whereas
transformation with the control vector pACYC184 relieved this repression. A purified STM0551 protein exhibited a
phosphodiesterase activity in vitro while a point mutation in the putative EAL domain, substituting glutamic acid (E)
with alanine (A), of STM0551 or a FimY protein abolished this activity.
Conclusions: The finding that the stm0551 gene plays a negative regulatory role in the regulation of type 1
fimbriae in S. Typhimurium has not been reported previously. The possibility that degradation of c-di-GMP is a key
step in the regulation of type 1 fimbriae warrants further investigation.
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Salmonella species are some of the most important
food-borne pathogens in the world. Members of the
genus Salmonella are gram-negative, facultative anaer-
obic rods which are composed of more than 2500 sero-
types [1]. Salmonella enterica serotype Typhimurium (S.
Typhimurium) is an important causative agent for
gastroenteritis. For most bacteria, adhesion to host epi-
thelial cells is the first step in establishing an infection.
Adhesion proteins or hair-like appendages called fim-
briae on the outer membranes of bacteria have been
implicated in adherence [2]. Whole-genome sequencing
identified 13 separate fimbrial gene clusters that may
have the potential to encode fimbria-associated proteins
in S. Typhimurium [3]. Among these, type-1 fimbriae
are the most commonly found type in S. Typhimurium,
as in other members of the family Enterobacteriaceae
[4]. In addition to adherence, type 1 fimbriae also con-
tribute to virulence and biofilm formation [5-7].
Phenotypic expression of type 1 fimbriae in S. Typhi-
murium involves the interaction and cooperation of
genes in the fim gene cluster. Briefly, FimA, FimI, FimF,
and FimH are structural proteins that are incorporated
to assemble a fimbrial shaft structure, while FimC and
FimD proteins located in the periplasmic space and on
the outer membrane respectively, function to transport
and anchor the fimbrial proteins. FimZ, FimY, FimW,
and an arginine transfer RNA fimU, regulate fimbrial
production by a complicated network [8-12]. Studies
also demonstrated that a global regulator, leucine-
responsive regulatory protein (Lrp), and other genes out-
side the fim gene cluster also take part in the regulatory
expression of type-1 fimbriae [13,14].
Bis-(3′–5′)-cyclic dimeric GMP (c-di-GMP) is a universal
second messenger that controls cell surface-associated
characters in bacteria [15]. Recent studies revealed the im-
portance of c-di-GMP in regulating many physiological
process such as adhesion, biofilm formation, exopolysac-
charide synthesis, virulence, and motility [16,17]. The cellu-
lar c-di-GMP concentration is regulated by diguanylate
cyclase (DGC) and phosphodiesterase (PDE). DGC cata-
lyzes the formation of c-di-GMP through a linear inter-
mediate, pppGpG, while PDE degrades it into guanosine
monophosphate (GMP). The most prominent conserved
protein domains in the PDE are EAL and HD-GYP [17].
An open reading frame named stm0551, located between
fimY and fimW, has not previously been investigated to de-
termine its involvement in type-1 fimbrial regulation in S.
Typhimurium (Figure 1). The amino acid sequence of the
STM0551 protein could encode a putative PDE. Multiple
alignments of the EAL domain of STM0551 with other
known PDE enzymes demonstrated the preservation of sev-
eral regions throughout the domain sequence >(Figure 2).
Since STM 3611 influences curli fimbrial expression in S.Typhimurium, and MrkJ controls type 3 fimbriae produc-
tion and biofilm formation in Klebsiella pneumoniae
[18,19], we decided to investigate whether stm0551 encodes
a functional PDE that plays a role in type 1 fimbrial
expression.
In the present study, a stm0551 mutant was con-
structed by allelic exchange. Phenotypic and genotypic
characteristics of this mutant were analyzed. Purified
STM0551 protein was tested for its putative function as
a PDE in vitro. A possible role of stm0551 in type 1 fim-
brial regulation in S. Typhimurium is discussed.
Results
Type 1 fimbrial expression by the S. Typhimurium
stm0551 mutant strain
The bacterial strains and plasmids used were described
in Table 1, while the primers used was indicated in
Table 2. The S. Typhimurium stm0551 knockout mutant
strain was constructed by a one-step gene inactivation
method [20]. Primers stm0551-F and stm0551-R exter-
nal to stm0551 amplified a 0.5-kb DNA fragment from
S. Typhimurium LB5010 genomic DNA, while the same
primer set generated a 1.3-kb DNA fragment from gen-
omic DNA of the S. Typhimurium stm0551 mutant
strain, indicating a kanamycin cassette inserted into the
stm0551 gene. This DNA fragment was also sequenced
to determine its identity. The confirmed stm0551 mu-
tant strain was then designated S. Typhimurium
Δstm0551. S. Typhimurium LB5010 mediated yeast ag-
glutination and guinea pig erythrocyte when cultured in
static LB broth, whereas agglutination was not detected
when cells were collected from LB agar (Table 3). In
contrast, the S. Typhimurium Δstm0551 strain mediated
agglutination when grown on LB agar. Nonetheless the
degree of agglutination was not as strong as the same
strain grown in static LB broth. Transformation of the
pSTM0551 plasmid that contains the coding sequence
of stm0551 conferred on S. Typhimurium Δstm0551
strain the ability to inhibit type 1 fimbrial expression in
both culture conditions, while the S. Typhimurium
Δstm0551 strain carrying a plasmid that possessed a
stm0551 coding sequence with the glutamic acid (E) at
position 49 replaced with an alanine (A), or a
pACYC184 cloning vector exhibited the same phenotype
as the S. Typhimurium Δstm0551 strain. The Figure 3
demonstrated the yeast agglutination tests performed on
glass slides.
Electron microscopy
S. Typhimurium LB5010 prepared in static LB broth cul-
ture demonstrated fimbrial appendages on the outer-
membrane of the cell (Figure 4, panel A). On the
contrary, S. Typhimurium LB5010 grown on agar
medium did not produce type1 fimbriae (Figure 4, panel











Figure 1 The genetic organization of the S. Typhimurium fim gene cluster and a possible regulatory network. The predicted sizes of the
Fim polypeptides are given in kilodaltons (kDa) with Arabic numbers. The arrows indicate the direction of transcription. The signal peptide region
of each gene product is shown as a small filled box. The established or postulated functions of the genes are indicated as follows: fimA, major
fimbrial subunit; fimI, minor fimbrial subunit; fimC, chaperone protein; fimD, molecular usher; fimH, adhesion protein; fimF, minor fimbrial subunit;
fimZ, regulatory protein; fimY, regulatory protein; stm0551, phosphodiesterase; fimW, regulatory protein; fimU, arginine tRNA. FimZ and FimY are
both required to activate fimA. FimW represses fimA expression and FimW interacts with FimZ physically to consume FimZ, diminishing available
FimZ to activate fimA. Leucine-responsive regulatory protein (Lrp) activates fimZ. fimU activate FimY translation. The function of stm0551 within
the fim regulatory circuit needs further characterization.
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static broth medium (Figure 4, panel C) or agar (Figure 4,
panel D) produced fimbrial structures.Quantitative RT-PCR analysis
Total RNA from LB5010, Δstm0551, Δstm0551
(pSTM0551), and Δstm0551 (pACYC184) strains were
prepared and analyzed for the fimbrial subunit gene,
fimA, and the regulatory genes, fimZ, fimY, and fimW,
by quantitative RT-PCR. 16 S ribosomal (r) RNA expres-
sion was used as a control. Individual gene expression
profiles were first normalized against the 16 S rRNA
gene and then compared to the expression level of fimA,
fimZ, fimY, and fimW obtained from agar. As for the
parental LB5010 strain, fimA expression obtained from
static LB broth was about 150-fold higher than the value
obtained from LB agar. The fimA expression of the
Δstm0551 strain grown on agar was significantly higher
than that of LB5010 grown on agar. Transformation of
Δstm0551 with a plasmid possessing the stm0551 coding
sequence repressed fimA expression whether this strain
was cultured on agar or in static broth, whereas trans-
formation of the same bacterial strain with the plasmid
cloning vector pACYC184 de-repressed fimA expression
in both culture conditions (Figure 5, panel A). The fimZ
expression levels from different strains demonstrated a
similar profile to that observed for fimA. The parental
LB5010 strain exhibited significant elevated level of fimZ
when grown in broth than on agar. The fimZ expression
of Δstm0551 was higher than that of the parental straingrown on agar. Transforming Δstm0551 with pSTM0551
repressed fimZ expression on both culture conditions,
while transforming Δstm0551 with pACYC184 cloning
vector de-repressed fimZ expression, leading to compar-
able level of expression as seen in the Δstm0551 strain
(Figure 5, panel B). However, the expression levels of
fimY were not significantly different between strains
under both growth conditions (Figure 5, panel C).
Δstm0551(pACYC184) had higher fimW expression than
Δstm0551(pSTM0551) did when both strains were cul-
ture on agar medium (Figure 5, panel D).PDE activity
Since the predicted amino acid sequence of STM0551
suggested that it was related to a family of proteins that
exhibit PDE activity, we determined whether STM0551
possessed PDE activity. The in vitro PDE activity of the
purified STM0551-His fusion protein was determined
using the specific substrate, bis (pNPP). The purified
FimY-His fusion protein was used as a control since FimY
amino acids exhibited no domain related to PDE activity.
STM0551 possesses “EVL” conserved residues that may
form the putative active site that varies from the consen-
sus “EAL” sequence. We constructed a substitution muta-
tion in which the glutamic acid (E) at position 49 was
replaced by alanine (A) in the stm0551 allele. A fusion
protein of this construct was prepared with the same pro-
cedure described for STM0551 and FimY and was
designed as STM0551E49A-His. The reactions that con-
tained STM0551 exhibited a statistically significant 1.75-
STM0551-LT2 1   MVAQGILLKERINPPHLASSPTRHSYLNSELLKSEPIVNL 
STM1344-LT2 2  IASLDELYHSELFFLPVMDENAR. . . . . . . . . 
STM3611-LT2 1   MIKQVIQQLRVPDAGIENLQERRYWLQCERAYTY.QPIYQ 
STM4626-LT2 255 IIILFMWSRSRQAYYSPRRLLQRAITRHQLCLHYQPIIDI 
MrkJ-KP      1   MNTKIFEDNILSRNDIAV. . RYVF. . . . .QKMFS 
***
STM0551-LT2 41 STAQLIGYEVLTQLPSEHDSEVFFQQ . . . . . . .  
STM1344-LT2 25 . . LVGLEIIATFAAEDGAVRMPTELVAPRLSVEEQYCL 
STM3611-LT2 40    TDGRLMAVELLTVVTHPDNPSRRIAPDRYFAELAVRHRID 
STM4626-LT2 295 RNGTCVGAEALLRWPGYHGPVMSPCEFIPLAEKEGMIEQI 
MrkJ-KP      28    PQGTLVAVECLSRFDNLSISPEDFFRHATAAVRERIFLEQ 
STM0551-LT2     . . . . . . . . . . . . . . . . . . . .  
STM1344-LT2 61 FVEKLALLETCQHFFIQHKLIAWLNLPPAISDLLLLDSEL 
STM3611-LT2 80    VVKEQLHQLEQKADFFTRHHLLASVNVDGPTLIAMRRQPD 
STM4626-LT2 335  TDYVVEEVFNDLGGFLAAHPHLYVSINLAAADFLSSRLIV 
MrkJ-KP      68    LALIEKHKAWFLRNHISATINVDDHILNLLRQKDIKAKIA 
STM0551-LT2     . . . . . . . . . . . . . . . . . . . .  
STM1344-LT2 101 FSRAARFPFLELAINENYPGLNQGKNNETLANLAMHFPLM 
STM3611-LT2 120  ILAAMERLPWLRFELVEHIRLPKDSSFASMCEFGPLWLDD 
STM4626-LT2 375 MIHEKTRQHSVLAQQIKVEVTERGFIDVPKMTPIIQAFRQ 
MrkJ-KP      108  ALTCVHFEVTENAENLLHNSLAAWQSPQDT. . SLWLDD 
STM0551-LT2      . . . . . . . . . . . . . . . . . . . .  
STM1344-LT2 141 LANFGAGEASTKAIFDGLFKRVMLDKNFIQQRAEMISFEP 
STM3611-LT2 160  FGTGMANFSALSEVRYDYIKVARELFVMLRQSPEGRNLFT 
STM4626-LT2 415 AGYEVAIDDFGTGYSNLHNLYSLNIDLLKIDKSFVDTLTT 
MrkJ-KP      144  FGSGYAGINAIRGYHFDYVKIDKDFFWHLMRKESGRQLMD 
STM0551-LT2 67   . . . . . .LMLMEGIETSEQRSIAFYAGATMEQGYLW
STM1344-LT2 184 AIVAQISSSCESLMIAGIDTEAMFARAAPLGFSAFQGGLW
STM3611-LT2 200  LLLQLMNRYCRGVIVEGVETLEEWRDVQRSPAFAAQGYFL
STM4626-LT2 464 HIIEMAQSLRLKIIAEGVETAEQVSWLLKRGVQYCQGWHF
MrkJ-KP      184  ALVTFLSRNHHNVIIEGVESEAHKEWLQGMEWFAIQGHYW
STM0551-LT2 96  PAILP. . . DIY
STM1344-LT2 224 P.PVPVSQL. .IKLVQR 
STM3611-LT2 240  SRPVPLISLEEVILTL 
STM4626-LT2 504 AKALPPQEF. .IAWLQQTPAPLTIRGQTPYRR 
MrkJ-KP      224  REVSIEQLVADDIAM 
Figure 2 Multiple sequence alignment of the EAL domain of STM0551 and other experimentally studied proteins. Residues showing
strict identity are written in white characters and highlighted in red. Similarity across groups is indicated with black characters and highlighted in
yellow. Putative catalytic active site residues within the EAL domain are marked with an asterisk. Protein names and microorganisms are as
follows: STM0551, STM1344, STM3611, STM4264: S. Typhimurium LT2; MrkJ: K. pneumoniae.
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that containing FimY and STM0551E49A (both reaction
mixtures contained the same amount of protein [10 μg])
(Figure 6). This result suggests that STM0551 could func-
tion as a PDE.
Discussion
The regulatory pathway of type 1 fimbriae in S. Typhimur-
ium involves several genes including the fim gene cluster
and other genes such as lrp [8-14]. The Salmonella patho-
genicity island 1 (SPI1) and flagellar systems also crosstalk
with type 1 fimbriae [23]. Several studies have indicated
that the mechanism controlling the intracellular c-di-
GMP concentration plays a critical role in regulating fim-
brial production. For example, MrkJ, a PDE, regulates
type-3 fimbrial production in Klebsiella pneumoniae [19].Deletion of mrkJ resulted in an increase in type-3 fimbrial
production [19]. In Escherichia coli S fimbriae are regu-
lated by a PDE, SfaY [24]. Production of CupA fimbriae of
Pseudomonas aeruginosa is controlled by both the GGDEF
domain in protein, PA1120, and PvrR that contains an
EAL domain [25]. The FimK of Klebsiella pneumoniae
contains the EAL domain and deletion of fimK conferred
hyperpiliation of type 1 fimbriae in this bacterium [26].
Our present finding may add one more example to this
fimbrial regulation/c-di-GMP concentration circuit.
The stm0551 gene of S. Typhimurium is located within
the fim gene cluster but has not previously been investi-
gated. The predicted amino acids of STM0551 showed
similarity to those of proteins with PDE activity, so it was
interesting to further dissect the function of stm0551 in
terms of type 1 fimbrial regulation. The parental strain S.
Table 1 Bacterial strains and plasmids used in this study
Name Description a Reference or source
Salmonella enterica serotype Typhimurium
LB5010 Wild type S. enterica serotype Typhimurium LT2
strain, fimbriate with the complete fim gene cluster
[21]
Δstm0551 stm0551 deletion mutant; Kanr Present study
Escherichia coli strain
One ShotW TOP10
chemically competent E. coli
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15
ΔlacX74 recA1 araD139Δ(ara-leu)7697 galU
galK rpsL (StrR) endA1 nupG
Invitrogen
BL21Star™ (DE3) One ShotW
chemically competent E. coli
F- ompT hsdSB(rB
- mB
- ) gal dcm (DE3) Invitrogen
Plasmids
pSTM0551 A 0.5-kb DNA fragment possessing the stm0551
coding sequence cloned into the pACYC184
vector; Cmr
Present study
pSTM0551E49A A 0.5-kb DNA fragment possessing the stm0551
coding sequence with glutamic acid (E) at
position 49 replaced with an alanine (A) cloned
into the pACYC184 vector; Cmr
Present study
pACYC184 Tetr, Cmr, cloning vector; w/p15A ori ATCC, Manassas, VA
pET101/D-TOPO Ampr, 6xHis tag expression vector Invitrogen
pKD46 Ampr, express λ Red recombinase system, temp-
sensitive replicon
[22]
pKD13 Plasmid carrying Kanr cassette [22]
a Ampr ampicillin resistant; Cmr chloramphenicol resistant; Kanr kanamycin resistant; Tetr tetracycline resistant
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variable fimbrial phase [21]. A static broth culture favors S.
Typhimurium to produce type 1 fimbriae, while non-
fimbriae phase bacteria were obtained by growth on solid
agar medium [27]. A stm0551 knockout mutant strain con-
structed in the present study enabled it to produce type 1
fimbriae on the solid LB agar medium. This phenotype was
correlated with the RT-PCR result that the mRNA expres-
sion of the major fimbrial subunit, fimA, was enhanced on
solid-agar culture medium. These suggested that stm0551
plays a repressive role in type 1 fimbrial regulation perhaps
in a similar manner to the role played by FimW in the fim
regulatory circuit [9]. The expression of fimA of the trans-
formant Δstm0551 (pSTM0551) grown on agar decreased
to the same level as that of the parental LB5010 strain
grown in the same conditions. However, this transformant
did not exhibit visible yeast agglutination and guinea pig
erythrocyte hemagglutination when grown in static broth,
nor did this strain exhibit fimA expression, which was un-
expected. One of the reasons could have been the relatively
high level of STM0551 production due to presence of the
multiple copies of the pSTM0551 recombinant plasmid in
these cells. An excessive STM0551 level in S. Typhimur-
ium could presumably cause a dramatically decreased con-
centration of c-di-GMP locally, and subsequently interfere
with fimA expression. However, the mechanism by whichSTM0551 interacts with fimA gene expression remains un-
clear. One possibility is that the stm0551 product main-
tained the local concentration of c-di-GMP at a level such
that only a certain amount of c-di-GMP was bound by a
hypothetical PilZ domain containing protein. This low con-
centration of c-di-GMP-bound, PilZ domain-containing
protein was not able to activate fimA gene expression. Dis-
ruption of stm0551 increased the local c-di-GMP concen-
tration and consequently also increased the “functional”
PilZ domain-containing protein to enhance fimA expres-
sion. The FimY protein of S. Typhimurium could possibly
function as such a PilZ domain-containing protein since
recently we found that the amino acid sequence of FimY
demonstrated relatedness to those of MrkH of K. pneumo-
niae and YcgR of the E. coli K-12 strain (data not shown).
Both MrkH and YcgR were shown to be transcriptional
activators with c-di-GMP-binding PilZ domains [28,29].
Our hypothesis about the role FimY correlates with the
finding that STM0551 did not affect fimY at the transcrip-
tional level (Figure 5, panel C). More detailed study of
FimY is necessary to define its role in a possible c-di-GMP
regulatory network. Both FimY and FimZ are required to
activate fimA expression in S. Typhimurium [8]. FimZ is a
DNA binding protein that binds the fimA promoter and
activate its expression [30]. Our qRT-PCR results demon-
strated very similar profiles for both fimA and fimZ
Table 2 Primers used in the present study
Purpose and name Sequence (5′ to 3′) Description








stm0551-F GGATCCCATCCTGCTTTTTCCATTGCTCTAATAT BamHI restriction site (underlined)
stm0551-R GATATCACTCACTTAACTTTTTACAAGGCTTACG EcoRV restriction site (underlined)
Annealing Temp.: 55°C; amplicon
length: 500 bp
Construction of the fusion protein
stm0551-TOPO-F CACCATGGTGGCACAGGGTATTTTGTTAA Annealing Temp.: 50°C; amplicon
length: 316 bp
stm0551-TOPO-R ATATATATCTGGTAATATGGCTGG
fimY-TOPO-F CACCATGCGCAGCGTACCACGCAG Annealing Temp.: 50°C; amplicon
length: 727 bp
fimY-TOPO-R AAAAATGTCGTGGAAAGTAACGT
E49A-TOPO-F ATCGGCTATGCGGTCCTGACGCAACTTCCG Mutation site (underlined)














Table 3 Phenotypic expression of type 1 fimbriae in S.
Typhimurium
Strain Plasmid transformed Phenotypic expression of
type-1 fimbriae a
agar broth
LB5010 none - ++
Δstm0551 none + ++
Δstm0551 pSTM0551 - -
Δstm0551 pSTM0551E49A + ++
Δstm0551 pACYC184 + ++
a Phenotypic expression of type-1 fimbriae was determined using a mannose-
sensitive yeast agglutination test and guinea pig erythrocyte hemagglutination
test
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http://www.biomedcentral.com/1471-2180/12/111expression (Figure 5, panel A and B). According to the
results reported by Saini et al., FimY and FimZ independ-
ently activate the fimA gene expression, in addition, FimY
and FimZ also activated each other’s expression [31]. In-
activation of stm0551 could possibly increase the local con-
centration of c-di-GMP, which results more c-di-GMP
bound FimY (active form) available to activate fimZ and
fimA, and eventually amplifies the fimA expression. FimW
is a repressor for fimA in S. Typhimurium. FimW may
achieve this repressive role by repressing fimY transcription
or by protein-protein interaction with FimZ [9,31]. In the
present study, little information was obtained regarding
how stm0551 may interact with fimW.
Strain Plasmid transformed Phenotypic expression of type-1 fimbriae 






Figure 3 Phenotypic expression of type 1 fimbriae in S. Typhimurium analyzed by yeast agglutination test. S. Typhimurium LB5010
prepared from broth medium exhibited positive agglutination phenotype, while those prepared from agar medium showed homogenous
appearance on the glass slide. Δstm0551 strain, prepared from either agar or broth medium, both demonstrated agglutination. Transforming
pSTM0551 into Δstm0551 inhibited agglutination. The transformants possessing either pSTM0551E49A or pACYC184 cloning vector exhibited the
same agglutination phenotype as Δstm0551 strain.
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ability to cleave the PDE-specific substrate, bis (pNPP),
in vitro, thus confirming the putative phosphodiesteraseFigure 4 Observation of S. Typhimurium LB5010 and the S. Typhimur
Typhimurium LB5010 obtained following growth under static LB broth con
(40,000 ×). Panel B: No fimbrial structures were observed on the S. Typhimu
Typhimurium Δstm0551 cells obtained from static LB broth condition at 37
the fimbrial appendages were also observed when these cells were culture
stained with 2% phosphotungstic acid.function assigned to it in the current databank. The con-
struct STM0551E49A-His contained a point mutation in
which the conserved glutamic acid residue at position 49ium Δstm0551 strain by electron microscopy. Panel A: S.
ditions at 37°C for 48 h produced type 1 fimbrial appendages
rium LB5010 grown on LB agar at 37°C for 18 hr (30,000 ×). Panel C: S.
°C for 48 h produced type 1 fimbrial appendages (15,000 ×) whereas
d on LB solid agar (panel D) (40,000 ×). Bacterial cells were negatively
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Figure 5 Detection of the relative transcript levels of fimA, fimZ, fimY, and fimW genes using quantitative RT-PCR. The mRNA transcript
levels of the major fimbrial subunit gene fimA (panel A), fimZ (panel B), fimY (panel C), and fimW (panel D) in the parental LB5010, Δstm0551,
Δstm0551 (pSTM0551), and Δstm0551 (pACYC184) strains were detected by quantitative RT-PCR. The mRNA transcript levels were obtained by
delta-delta Ct (ΔΔCt) method, and the expression levels (2-ΔΔCt) of the parental LB5010 strain cultured on LB agar were set to 1 fold for each
gene tested. The asterisk indicated that the differences in transcript levels were statistically significantly (p<0.05).
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residue; the STM0551E49A mutant protein was unable to
cleave bis (pNPP). In accordance with this result, when
the STM0551E49A-containg construct cloned into a
pACYC184 vector (pSTM0551E49A) was transformed
into Δstm0551, the resulting transformant exhibited the
same phenotype as that of Δstm0551 or Δstm0551 posses-
sing pACYC184 cloning vector (Table 3). This further sug-
gested that the glutamic acid at position 49 of STM0551
did play a critical role for phosphodiesterase activity.
Therefore, the in vivo agglutination phenotype results cor-
related with the in vitro phosphodiesterase activity result.
In addition, the purified FimY protein, a positive regulator
of type 1 fimbriae, also did not demonstrate such activity.
Our results indicated that STM0551 has PDE activity
in vitro. Currently, we can only say that stm0551 takes part
in the complicated type 1 fimbrial regulatory network and
play a repressive role. We have no direct evidence about
whether stm0551 actually modulates the concentration ofthe c-di-GMP pool in S. Typhimurium to achieve its im-
pact on fim gene regulation. Although the determination of
the intracellular concentration of c-di-GMP of Δstm0551
mutants warrants further investigation, this may be prove
to be difficult because the c-di-GMP concentration fluctu-
ates locally, due to the spatial compartmentalization of pro-
teins [32]. One example of this phenomenon is that the
majority of the c-di-GMP in Acetobacter xylinum is bound
by a membrane protein and is released only in response to
certain signals [33]; therefore we need to take into consid-
eration that the actual and measured concentrations of c-
di-GMP might be different.
Besides fimbrial production, it is interesting to investi-
gate whether stm0551 can influence other phenotypes of
S. Typhimurium. We tested the ability of bacteria to form
biofilm, swimming and swarming motility, and the ability
to bind Congo red (rdar morphotype) in the LB5010 and
Δstm0551strains, but both strains exhibited the same














Figure 6 Phosphodiesterase activity. In vitro phosphodiesterase activity assays compared the abilities of the purified STM0551-6xHis, FimY-
6xHis, and STM0551E49A-6xHis proteins to cleave the specific substrate, bis (pNPP). Release of p-nitrophenol was determined at 410 nm. * p<0.05.
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which encodes a PDE, play a regulatory role in the pro-
duction of type 1 fimbriae in S. Typhimurium.Conclusions
The c-di-GMP pathway is used by most bacteria (but not
eukaryotes or Archaea) to regulate numerous biological
processes [36]. Several lines of evidence have indicated the
concentration of c-di-GMP, balanced by diguanylate
cyclase (DGC) and phosphodiesterase (PDE), account for
the fimbrial regulatory network in some microorganisms.
In S. Typhimurium, it has been demonstrated that produc-
tion of curli fimbriae was inhibited by a PDE STM3611
[18]. However, no other type of fimbrial expression in this
microorganism has thus far been shown to be controlled
by DGC or PDE. The present study revealed that a previ-
ously uncharacterized stm0551 gene, which could encode
a PDE, contributes to the down-regulation of type 1 fim-
brial expression in S. Typhimurium. Our finding may pro-
vide valuable information that may help to further
elucidate the complicated type 1 fimbrial regulatory circuit
in this pathogen.Methods
Bacterial strains, plasmids, and culture media
The bacterial strains, plasmids, and primers used in the
present study are listed in Table 1 and Table 2. The S.
Typhimurium strain used was LB5010, an LT2 derivative
[21]. This strain produces type 1 fimbriae and has a variablefimbrial phase. Bacteria were cultured in Luria-Bertani (LB)
broth (Difco/Becton Dickinson, Franklin Lakes, NJ) or pla-
ted on LB agar. When required, media were supplemented
with antibiotics at the following concentrations: 100 μg/ml
ampicillin, 50 μg/ml kanamycin, and 20 μg/ml chloram-
phenicol. Antibiotics were obtained from Sigma (St. Louis,
MO). To detect gene expression, 1 mM of isopropyl-β-D
-thiogalactopyranoside (IPTG) was used (MDbio, Taipei,
Taiwan).Construction of a S. Typhimurium stm0551 mutant
A stm0551 mutant was created by one-step gene inactiva-
tion method as described previously [20]. Briefly, a
kanamycin-resistance gene from pKD13 tagged with a
flanking sequence of the stm0551 gene was generated by a
polymerase chain reaction (PCR) technique. The designed
nucleotide sequence was generated with Pfu polymerase
(Fermentas, St. Leon-Rot, Germany) on a GeneAmp PCR
system 2700 thermal cycler (Applied Biosystems, Foster
City, CA) and initially incubated at 94 ° C for 3 min, fol-
lowed by 30 cycles of 94°C for 1 min, 50°C for 1 min, and
72°C for 2 min. Primers used in this approach are listed in
Table 3. Then, the PCR product was introduced by electro-
poration into S. enterica serotype Typhimurium LB5010
possessing the pKD46 plasmid which expressed λ Red re-
combinase [20]. All transformants were grown on LB agar
containing kanamycin. The constructed mutants were veri-
fied by PCR with primers located in the flanking sequence
of the stm0551 gene.
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hemagglutination test for type 1 fimbriae
Tested bacteria were cultured in static LB broth at 37°C for
48 h or on LB agar at 37°C overnight. Bacterial cells in
static-broth medium were collected by centrifugation, and
the pellet was resuspended in 100 μl of 1× phosphate-
buffered saline (PBS). Bacteria from LB agar were scraped
with a sterile loop and resuspended in 300 μl of 1× PBS.
Subsequently, 30 μl of a 3% (vol/vol) suspension of Sac-
charomyces cerevisiae (Sigma) or guinea pig red blood cells
in PBS and an equal amount of bacterial cells to be tested
were mixed on a glass slide [27]. Visible agglutination after
gentle agitation indicated a positive reaction for type 1 fim-
briae. The presence of mannose-sensitive yeast cell agglu-
tination or mannose-sensitive guinea pig erythrocyte
hemagglutination was determined by mixing the bacterial
suspension with PBS containing 3% (w/v) α-methyl-D
-mannoside (Sigma).
Electron microscopy
The bacterial strains tested were grown in static broth or
on solid agar and resuspended in 1×PBS. The bacterial
cells were then negatively stained with 2% phosphotungs-
tic acid and observed with a Hitachi H-600 transmission
electron microscope (Hitachi Ltd., Tokyo, Japan).
Complementation test
Primers used for the complementation test (stm0551-F
and stm0551-R) are listed in Table 2 and were used to
amplify genomic DNA of S. Typhimurium LB5010. The
PCR product that possessed the full coding sequence of
stm0551 was cloned into the pACYC184 vector using T4
DNA ligase (Fermentas). To construct a stm0551 allele
with the glutamic acid at position 49 replaced with an ala-
nine; stm0551-F and E49A-TOPO-R were used to amplify
the first DNA fragment using Pfu DNA polymerase (Fer-
mentas). The PCR conditions were: denaturing at 94°C for
3 min followed by 35 cycles of 94°C for 45 sec, 50°C for
45 sec and 72°C for 45 sec. The second DNA fragment was
amplified using E49A-TOPO-F and stm0551-R with the
same procedure described above. These two DNA frag-
ments were purified by Montage Gel Extraction Kit (Milli-
pore, Billerica, MA). Ligation of these two DNA fragments
having two overlapping ends was achieved with stm0551-F
and stm0551-R primers as follows: denaturation at 94°C
for 3 min, ligation at 50°C for 45 sec and elongation at 72°
C for 45 sec, followed by 35 cycles of 94°C for 45 sec., 50°C
for 45 sec, and 72°C for 45 sec. Amplified DNA fragment
was digested with BamHI and EcoRV and cloned into
pACYC184 vector to generate pSTM0551E49A. The
mutated stm0551 allele of this plasmid was sequenced to
confirm if the glutamic acid (E) at position 49 was replaced
by alanine (A) before transforming into the S. Typhimur-
ium Δstm0551 strain by electroporation. The pACYC184cloning vector was also transformed into the S. Typhimur-
ium Δstm0551 strain as a control.
Quantitative RT-PCR analysis
Total bacterial RNA was isolated using an RNeasy Mini
Kit (Qiagen, Hilden, Germany) according to the manu-
facturer’s protocol. Subsequently, RNA was treated with
RNase-free DNase (1 unit/1 μg RNA) to remove con-
taminating genomic DNA. The purified RNA was con-
verted to cDNA using a MMLV reverse transcriptase
method in the following steps: First, 100 ng of the total
RNA was annealed with 100 nM specific primers by
heating to 65°C for 2 min and then cooled on ice for
1 min. Next, 1 U of RNasin, 2 μl of 100 mM DTT, 1 μl
of 10 mM dNTP and 0.5 μl of 200 U/μl MMLV High
Performance Reverse Transcriptase (Epicentre, Madison,
WI) were added to each RNA/primer mixture and incu-
bated at 37°C for 1 h, followed by heating at 85°C for
10 min to inactivate the enzyme and then chilled on ice
for at least 1 min. The specific cDNA that we prepared
was used in the following quantitative real-time PCR
analysis. The components of real-time PCR were pre-
pared by adding 10 ng of each specific cDNA and 1 μl of
a 10 mM primer solution to 2 ×Maxima SYBR Green/
ROX qPCR Master Mix (Fermentas) and adjusted with
ddH2O to a final volume of 20 μl. Cycling conditions
were performed using Roche LightCycler 2.0 system
(Roche Applied Science, Branford, CT) as follows: 95°C
for 2 min followed by 40 cycles of 95°C for 30 sec, 50°C
for 30 sec and 72°C for 15 sec. Dissociation curves and
non-template controls were included to detect any pri-
mer dimerization or other artifacts. The mRNA tran-
script levels were obtained by the method described by
Livak and Schmittgen [37].
Fusion protein construction
A carboxy terminal 6×histidine-tagged fusion to STM0551
was constructed by amplifying stm0551 with primers
stm0551-TOPO-F and stm0551-TOPO-R using genomic
DNA of S. Typhimurium LB5010 as the template. The
resulting 316-bp PCR product was cloned into the
pET101/D-TOPO vector (Invitrogen, Carlsbad, CA) giving
rise to plasmid pSTM0551-His. This recombinant plasmid
was sequenced at the adjacent portion of the cloning site to
make sure it was in frame before subsequent transform-
ation step. BL21Star™ (DE3) One ShotW chemically compe-
tent E. coli (Invitrogen) cells were transformed with
pSTM0551-His. Log phase cultures were induced to ex-
press STM0551-His by adding 1 mM IPTG at 37°C for
4 hr. The STM0551-His fusion protein was further purified
by ProBond purification kit (Invitrogen) using the protocol
provided by the manufacturer. The protein concentration
was determined using the Bradford reagent (Fermentas)
[38]. A mutant allele of stm0551 was constructed by site-
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S. Typhimurium LB5010 strain genomic DNA template
and mutagenic oligonucleotides E49A-TOPO-F and E49A-
TOPO-R [39]. Briefly, STM0551-TOPO-F and E49A-
TOPO-R were used to amplify the first DNA fragment
using Pfu DNA polymerase (Fermentas). The PCR condi-
tions were: denaturing at 94°C for 3 min followed by 35
cycles of 94°C for 45 sec, 50°C for 45 sec and 72°C for
45 sec. The second DNA fragment was amplified using
E49A-TOPO-F and STM0551-TOPO-R with the same
procedure described above. These two DNA fragments
were purified by Montage Gel Extraction Kit (Millipore,
Billerica, MA). Ligation of these two DNA fragments hav-
ing two overlapping ends was achieved with STM0551-
TOPO-F and STM0551-TOPO-R primers as follows: de-
naturation at 94°C for 3 min, ligation at 50°C for 45 sec
and elongation at 72°C for 45 sec, followed by 35 cycles of
94°C for 45 sec., 50°C for 45 sec, and 72°C for 45 sec. Amp-
lified fragments were cloned into pET101/D-TOPO vector
and sequenced to determine if the glutamic acid (E) at pos-
ition 49 was replaced by alanine (A). The resulting recom-
binant plasmid was designed as pSTM0551E49A-His.
Further protein induction and purification were performed
using the same procedure as for STM0551-His fusion pro-
tein. Similarly FimY-His fusion protein was constructed
using fimY-TOPO-F and fimY-TOPO-R primers.
PDE activity assay
In vitro PDE activity assays were performed using puri-
fied STM0551-His, STM0551E49A-His and FimY-His
proteins. Test protein was suspended in the assay buffer
(50 mM Tris–HCl and 1 mM MnCl2, pH 8.5) supple-
mented with 5 mM bis (p-nitrophenol) phosphate (bis-
pNPP) as previously described [40,41]. Reactions were
incubated at 37°C overnight. The release of p-nitrophe-
nol was quantified at OD410 in a spectrophotometer
(WPA Biowave II, Cambridge, UK).
Statistical analysis
All statistical data were analyzed using Student’s t-test.
Differences in measurements with a p value of< 0.05 were
considered to be significant.
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